|
|
13800 N.W. 2nd Street, Suite 190 Sunrise, FL 33325 USA phone:(1) 954 315 6600 fax:(1) 954 315 6601
|
|
| Symbol |
Private |
| Founded |
2002 |
| Employees |
|
|
|
| www.abrika.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Drug delivery technologies for generic and proprietary pharmaceutical products. |
 |
| Management |
| Alan Cohen, R.Ph.- Chairman and General Partner;
James New, Ph.D., M.B.A.- Chief Executive Officer;
Scott Lodin, JD- Senior Vice President and General Counsel;
Tim Weng, Ph.D.-Sr. Vice President of Research & Development; Dale Martin, M.B.A.-Vice President of Corporate Development |
| |
|
|
| |
|
| Keywords |
| drug delivery, generic, pharmaceutical, DrugDelivery |
|
|
|
| Description |
|
Abrika Pharmaceuticals develops drug delivery technologies to commercialize a portfolio of generic pharmaceutical products and proprietary branded drugs. |
 |
| Products / Services |
These formulations include a variety of oral solid dosage forms like tablets, minitablets, coated tablets, specially shaped coated tablets, hard capsules, coated capsules, liquid filled capsules, granules, pellets, microparticles, and coated granules and pellets, as well as transmucosal and transdermal delivery.
|
 |
| Technology / Differentiation |
| The company's suite of drug delivery technologies covers a wide range approaches that allow it to produce formulations of drugs with controlled and immediate release characteristics. |
 |
| Market / Customers |
Bethanechol Chloride; Ciprofloxacin HCL; Isradipine Capsules; Nystatin
|
 |
|
|
|
|
|
|